Senate stresses adoption of pricing formula for drugs

Mechanism to streamline and reduce medicine prices.


Ppi May 27, 2013
PHOTO: FILE

KARACHI: Senate Standing Committee on National Regulations and Services has stressed on the formulation of a pricing formula for drugs by the Drug Regulatory Authority of Pakistan (Drap) as a first basic step to determine prices of medicines in Pakistan.

In a meeting, Senator Abdul Haseeb Khan demanded that to investigate artificial increase in prices of 37 medicines through “hardship cases”, the case should be sent to the Federal Investigation Agency for inquiry.

Khan was of the view that the proposed pricing formula will ensure a fall in prices of the drugs produced in the country up to 70%.

In the meeting, Khan emphasised that the base of pricing formulae should be “quality products at affordable price”.

When he suggested that the scrutiny of 500 drug manufacturers should be done on the basis of good manufacturing practice (GMP) compliance, the Minister of National Regulations and Services (NRS) directed the Secretary NRS to form a GMP Compliance Committee immediately.

It was suggested that price rationalisation initiative shall be applied as a top priority based on whether the product is branded or not. Formula applied for calculating the selling price should be based on the premise that manufacturing cost should be 20% of the ex-factory price.



To improve the quality of medicines, use of API based on current pharmacopoeia standards shall be strictly enforced.

The committee showed its dissatisfaction over non-conformity of any formula adopted for registration of drug prices. It was said that disparity factor existed in drug prices throughout the country.

In terms of hardship cases, Amanullah, director (Costing and Pricing) told the committee that no set formula was available. Thereafter, a comparative analysis of five different pricing formulae was displayed.

The issues were unanimously recommended by the committee and it was suggested that the Ministry of NRS may also consider the formulae proposed by the committee, Pharma Bureau and Pakistan Pharmaceutical Manufacturers Association.

Published in The Express Tribune, May 28th, 2013.

Like Business on Facebook to stay informed and join in the conversation.

COMMENTS (1)

knockdown. | 8 years ago | Reply

Farooq Awan is secretary health so should expect all this. from Musharraf regime the guy was in EOBI, involved in billion rupees scam of 2008 stock market crash. Then went to Telecommunication ministry and crafted the ICH drama to make billions from kickbacks and share price manipulation of PTCL and final move in health ministry to raise price of live saving drugs by 500%. Soon we will have price manipulations in Pharma sector at KSE.

Bureaucracy shall eat up this country.

Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ

E-Publications

Most Read